Our Companies

DormoTech

DormoTech Medical Ltd. is a Digital Health company, specializing in monitoring and diagnosis of sleep disorders. A new generation of home diagnostic device that is personal, reusable, small, easy to use, and multi-channel, sophisticated and is designed to enable a new business model based on the new standards of digital health. The Device will dramatically change the sleep assessment scene for both adults and children.

The Need

There has been a significant global increase in people suffering from sleep disorders that severely impairs quality of life and health for both patient and their families. The increasing cost of sleep tests has driven HMO’s to home sleep tests controlled by traditional sleep labs.

However, current home devices are not suggesting full sleep home tests, they still require considerable maintenance and handling, they do not offer the simple workflow that is required to reduce operational cost and to perform the tests easily and successfully in home according to the new codes of digital healthcare. This is what we aim to.

Status

Founded
2018
Incubated
2020
Development Stage
R&D

DormoTech’s Solution

DormoTech’s patent-pending Vlab™ provides an end-to-end testing cycle, including a single-patient device, intuitive and simplified scoring and reporting systems that use a novel machine-assisted scoring approach. Our device complies and exceeds the requirements of Centers for Medicare & Medicaid Services (CMS) and American Association of Sleep Medicine (AASM).

Abed Naser, MSc, MBA, CEO

M.Sc.&B.Sc. in Bio-Medical Engineering, MBA Big data and finance &accounting, Tel-Aviv University.
10 years of experience in medical device and pharmaceutical industry, Technology transfer and global system development and implementation in leading companies.

Ofer Barnea, PhD, CSO

Professor of Biomedical Engineering and former chairman of the Department of BME at TAU. BSc in EE@TAU; PhD in BME at Drexel. 30 years’ experience in the medical device industry. Founded several companies and led the development of medical devices as a consultant

The Market Opportunity

According to the American Sleep Association, in 2015, over 21% of women in the U.S. were suffering from obstructive sleep apnea and over 34% of men were suffering from sleep apnea.  40M Americans suffer from SA. Sleeping Aids Market Size to Hit $101.9 Billion by 2023: P&S Market Research Sleep apnea devices are predicted to be the fastest growing product category in this market, witnessing CAGR of 7.4% during the coming 5 years.